Okadaic acid-induced Tau phosphorylation in rat brain: Role of NMDA receptor

Neuroscience

Volumn 238, Issue , 2013, Pages 97-113

  Kamat, P K ^a   Rai, S ^b   Swarnkar, S ^b   Shukla, R ^b   Ali, S ^c   Najmi, A K ^c   Nath, C ^b  

^a University of Louisville School of Medicine   (United States)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c HAMDARD UNIVERSITY   (India)

Author keywords

Alzheimer's disease; Donepezil; Memantine; NMDA; Okadaic acid; Tau

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALPAIN; DIZOCILPINE; DONEPEZIL; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; TAU PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN TISSUE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II GENE; CALCIUM CELL LEVEL; CARBOXY TERMINAL SEQUENCE; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVITY; GENE ACTIVITY; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3BETA GENE; HIPPOCAMPUS; LATENT PERIOD; MALE; MAZE TEST; MEMORY DISORDER; NEUROTOXICITY; NONHUMAN; PHOSPHOPROTEIN PHOSPHATASE 2A GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; TAU GENE;

ANIMALS; BRAIN; CALCIUM; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CALPAIN; CHOLINERGIC ANTAGONISTS; DIZOCILPINE MALEATE; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GLYCOGEN SYNTHASE KINASE 3; INDANS; MALE; MAZE LEARNING; MEMANTINE; NEURONS; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; TAU PROTEINS;

EID: 84876027041     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.01.075     Document Type: Article

References (46)

1. Akasofu S., Kimura M., Kosasa T., Ogura H., Sawada K. Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-d-aspartate (NMDA) toxicity. Eur J Pharmacol 2006, 530:215-222.
2. Balaraman Y., Limaye A.R., Levey A.I., Srinivasan S. Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance. Cell Mol Life Sci 2006, 63:1226-1235.
3. Ballatore C., Lee V.M., Trojanowski J.Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 2007, 8:663-672.
4. Baudier J., Cole R.D. Phosphorylation of Tau proteins to a state like that in Alzheimer's brain is catalyzed by a calcium/calmodulin-dependent kinase and modulated by phospholipids. J Biol Chem 1987, 262:17577-17583.
5. Bondareff W., Harrington C.R., McDaniel S.W., Wischik C.M., Roth M. Presence of axonal-paired helical filament-Tau in Alzheimer's disease: submicroscopic localization. J Neurosci Res 1994, 38:664-669.
6. Choi D.W. Calcium and excitotoxic neuronal injury. Ann N Y Acad Sci 1994, 747:162-171.
7. Cohen H.A., McGovern S.A. Identity of " dumbbell" profiles in synaptosomal fractions from rat brain. J Neurobiol 1973, 4:583-587.
8. Diaz-Hernandez M., Gomez-Ramos A., Rubio A., Gomez-Villafuertes R., Naranjo J.R., Miras-Portugal M.T., Avila J. Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular Tau. J Biol Chem 2010, 285:32539-32548.
9. Ekinci F.J., Ortiz D., Shea T.B. Okadaic acid mediates Tau phosphorylation via sustained activation of the L-voltage-sensitive calcium channel. Brain Res Mol Brain Res 2003, 117:145-151.
10. Garg S., Timm T., Mandelkow E.M., Mandelkow E., Wang Y. Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17kD fragment. Neurobiol Aging 2011, 32:1-14.
11. Ghoshal N., Garcia-Sierra F., Wuu J., Leurgans S., Bennett D.A., Berry R.W., Binder L.I. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol 2002, 177:475-493.
12. Giese K.P. GSK-3: a key player in neurodegeneration and memory. IUBMB Life 2009, 61:516-521.
13. Giese K.P., Fedorov N.B., Filipkowski R.K., Silva A.J. Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning. Science 1998, 279:870-873.
14. Glowinski J., Iversen L. Regional studies of catecholamines in the rat brain. 3. Subcellullar distribution of endogenous and exogenous catecholamines in various brain regions. Biochem Pharmacol 1966, 15:977-987.
15. Goedert M., Klug A., Crowther R.A. Tau protein, the paired helical filament and Alzheimer's disease. J Alzheimers Dis 2006, 9:195-207.
16. Gong C.X., Wang J.Z., Iqbal K., Grundke-Iqbal I. Inhibition of protein phosphatase 2A induces phosphorylation and accumulation of neurofilaments in metabolically active rat brain slices. Neurosci Lett 2003, 340:107-110.
17. Gong C.X., Wegiel J., Lidsky T., Zuck L., Avila J., Wisniewski H.M., Grundke-Iqbal I., Iqbal K. Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain. Brain Res 2000, 853:299-309.
18. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260:3440-3450.
19. Higuchi M., Iwata N., Matsuba Y., Takano J., Suemoto T., Maeda J., Ji B., Ono M.S., Taufenbiel M., Suhara T., Saido T.C. Mechanistic involvement of the calpain-calpastatin system in Alzheimer neuropathology. FASEB J 2011, 26:1204-1217.
20. Kamat P.K., Tota S., Saxena G., Shukla R., Nath C. Okadaic acid (ICV) induced memory impairment in rats: a suitable experimental model to test anti-dementia activity. Brain Res 2010, 1309:66-74.
21. Kamat P.K., Tota S., Shukla R., Ali S., Najmi A.K., Nath C. Mitochondrial dysfunction: a crucial event in okadaic acid (ICV) induced memory impairment and apoptotic cell death in rat brain. Pharmacol Biochem Behav 2011, 100:311-319.
22. Kimura T.S., Yamashita, et al. GSK-3beta is required for memory reconsolidation in adult brain. PLoS One 2008, 3(10):e3540.
23. Li M., Ona V.O., Guegan C., Chen M., Jackson-Lewis V., Andrews L.J., Olszewski A.J., Stieg P.E., Lee J.P., Przedborski S., Friedlander R.M. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 2000, 288:335-339.
24. Loring J.F., Wen X., Lee J.M., Seilhamer J., Somogyi R. A gene expression profile of Alzheimer's disease. DNA Cell Biol 2001, 20:683-695.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
26. Maehama T., Taylor G.S., Slama J.T., Dixon J.E. A sensitive assay for phosphoinositide phosphatases. Anal Biochem 2000, 279:248-250.
27. Martin L., Page G., Terro F. Tau phosphorylation and neuronal apoptosis induced by the blockade of PP2A preferentially involve GSK3beta. Neurochem Int 2011, 59:235-250.
28. Mattson M.P. Calcium and free radicals: mediators of neurotrophic factor and excitatory transmitter-regulated developmental plasticity and cell death. Perspect Dev Neurobiol 1996, 3:79-91.
29. Mattson M.P., Rydel R.E. Beta-amyloid precursor protein and Alzheimer's disease: the peptide plot thickens. Neurobiol Aging 1992, 13:617-621.
30. Maynes J.T., Bateman K.S., Cherney M.M., Das A.K., Luu H.A., Holmes C.F., James M.N. Crystal structure of the tumor-promoter okadaic acid bound to protein phosphatase-1. J Biol Chem 2001, 276:44078-44082.
31. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 1984, 11:47-60.
32. Parsons C.G., Gilling K. Memantine as an example of a fast, voltage-dependent, open channel N-methyl-d-aspartate receptor blocker. Methods Mol Biol 2007, 403:15-36.
33. Partridge R.S., Monroe S.M., Parks J.K., Johnson K., Parker W.D., Eaton G.R., Eaton S.S. Spin trapping of azidyl and hydroxyl radicals in azide-inhibited rat brain submitochondrial particles. Arch Biochem Biophys 1994, 310:210-217.
34. Paxinos G., Watson C.R., Emson P.C. AChE-stained horizontal sections of the rat brain in stereotaxic coordinates. J Neurosci Methods 1980, 3:129-149.
35. Peineau S., Bradley C., Taghibiglou C., Doherty A., Bortolotto Z.A., Wang Y.T., Collingridge G.L. The role of GSK-3 in synaptic plasticity. Br J Pharmacol 2008, 153(Suppl. 1):S428-S437.
36. Reynolds C.H., Garwood C.J., Wray S., Price C., Kellie S., Perera T., Zvelebil M., Yang A., Sheppard P.W., Varndell I.M., Hanger D.P., Anderton B.H. Phosphorylation regulates Tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cgamma1, Grb2, and Src family kinases. J Biol Chem 2008, 283:18177-18186.
37. Serrano L., Montejo de Garcini E., Hernandez M.A., Avila J. Localization of the tubulin binding site for Tau protein. Eur J Biochem 1985, 153:595-600.
38. Sontag E., Hladik C., Montgomery L., Luangpirom A., Mudrak I., Ogris E., White C.L. Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J Neuropathol Exp Neurol 2004, 63:1080-1091.
39. Sontag E., Luangpirom A., Hladik C., Mudrak I., Ogris E., Speciale S., White C.L. Altered expression levels of the protein phosphatase 2A AB alpha C enzyme are associated with Alzheimer disease pathology. J Neuropathol Exp Neurol 2004, 63:287-301.
40. Steiner B., Mandelkow E.M., Biernat J., Gustke N., Meyer H.E., Schmidt B., Mieskes G., Soling H.D., Drechsel D., Kirschner M.W., et al. Phosphorylation of microtubule-associated protein Tau: identification of the site for Ca2(+)-calmodulin dependent kinase and relationship with Tau phosphorylation in Alzheimer tangles. EMBO J 1990, 9:3539-3544.
41. Torrent L., Ferrer I. PP2A and Alzheimer disease. Curr Alzheimer Res 2012, 9:248-256.
42. Trinchese F., Fa M., Liu S., Zhang H., Hidalgo A., Schmidt S.D., Yamaguchi H., Yoshii N., Mathews P.M., Nixon R.A., Arancio O. Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. J Clin Invest 2008, 118:2796-2807.
43. Van Westerlaak M.G., Joosten E.A., Gribnau A.A., Cools A.R., Bar P.R. Differential cortico-motoneuron vulnerability after chronic mitochondrial inhibition in vitro and the role of glutamate receptors. Brain Res 2001, 922:243-249.
44. Vogelsberg-Ragaglia V., Schuck T., Trojanowski J.Q., Lee V.M. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus. Exp Neurol 2001, 168:402-412.
45. 2+/calmodulin-dependent protein kinase II-discovery, progress in a quarter of a century, and perspective: implication for learning and memory. Biol Pharm Bull 2005, 28:1342-1354.
46. Yi K.D., Simpkins J.W. Protein phosphatase 1, protein phosphatase 2A, and calcineurin play a role in estrogen-mediated neuroprotection. Endocrinology 2008, 149:5235-5243.